StonvexLoading…
StonvexStonvexStonvexCore line items from OSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $143.38M | $92.02M | $51.28M | $30.70M |
Operating Income | $-101.01M | $-59.84M | $-24.22M | $-35.71M |
Net Income | $-259.09M | $-556.09M | $4.95M | $522.12M |
EPS (Diluted) | $-5.93 | $-11.96 | $0.18 | $11.48 |
Total Assets | $2.22B | $8.06B | $8.43B | $7.97B |
Total Liabilities | $1.14B | $6.86B | $7.00B | $6.65B |
Cash & Equivalents | $70.09M | $29.61M | $7.34M | $6.33M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 45.01M | 46.51M | 45.20M | 44.97M |